Trials / Withdrawn
WithdrawnNCT01467635
EBUS-TBNA Versus EBUS-TBNB
Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA) Versus Endobronchial Ultrasound Transbronchial Needle Biopsy (EBUS-TBNB) in the Assessment of Mediastinal and Hilar Lymphadenopathy: a Randomised Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective diagnostic clinical study randomising patients undergoing endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) of enlarged mediastinal and hilar lymph nodes to have sampling using the usual EBUS-TBNA needle or a novel biopsy forceps (EBUS-TBNB). The study aims to establish whether the use of EBUS-TBNB can significantly increase the diagnostic yield over EBUS-TBNA, without an increase in complication rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endobronchial ultrasound guided lymph node sampling | Patients with enlarged mediastinal or hilar lymph nodes have these sampled under endobronchial ultrasound guidance using either the EBUS-TBNA needle or the EBUS-TBNB biopsy forceps. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2011-11-09
- Last updated
- 2016-07-13
Locations
3 sites across 2 countries: Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01467635. Inclusion in this directory is not an endorsement.